Latest News

  • GE HealthCare, AWS Collaborate on Gen AI Models

    Diagnostics World | GE HealthCare and Amazon Web Services have announced a strategic collaboration to develop purpose-built foundation models and generative artificial intelligence (AI) applications designed to help clinicians improve medical diagnostics and patient care.

    Aug 6, 2024
  • ‘Reimagined’ Community Pharmacists To Do More Point-of-Care Testing

    Diagnostics World | Evidence is mounting that public health in the U.S. could get a big boost by better engaging community pharmacists in providing acute and chronic care services. These are highly trained clinicians in “extremely accessible” locations no more than five miles from the home of 95% of Americans.

    Aug 1, 2024
  • Alzheimer’s Disease Blood Testing Matures

    Diagnostics World | A study published in JAMA yesterday suggests blood tests can more accurately detect Alzheimer’s disease than physicians, and points to a way forward for more extensive Alzheimer’s testing. More blood testing developments are on display at this week's Alzheimer’s Association International Conference.

    Jul 29, 2024
  • Boehringer Ingelheim Teams Up With Brainomix, New Diagnostic For Multiple Sclerosis, More

    Diagnostics World | Researchers at The Australian National University (ANU) have developed a deep learning algorithm, known as DEPLOY, to classify central nervous system tumors into 10 major categories from histopathology images. The goal is to optimize treatment with a faster, more accessible diagnostic approach than the state-of-the-art practice of DNA methylation-based profiling, which can take weeks.

    Jul 25, 2024
  • Element Biosciences Commercializing Platform, NOWDiagnostics At-Home Tests, More

    Diagnostics World | Element Biosciences nets $277 million to launch combined sequencing and cyto-profiling platform; NOWDiagnostics raises $22.5 million for at-home diagnostic tests; and more.

    Jul 24, 2024
  • Grassroots Initiative Helping Clinicians Better Treat Rare Disease Patients

    Diagnostics World | A new web-based platform aims to standardize the care of rare disease patients in a wide range of settings and accelerate their diagnostic journey. The Rare Disease Clinical Activity Protocols (RareCAP) is effectively a collection of the latest research-based information and guidance about some of the more than 7,000 conditions affecting a small number of people.

    Jul 23, 2024
  • Cardiac Sarcoidosis: Exploring a Rare and Difficult-to-Diagnose Disease

    Diagnostics World | Most of the time, sarcoidosis appears in the lungs and lymph nodes, but the heart is impacted in a smaller number of patients. Known as cardiac sarcoidosis (CS), this rare condition can lead to serious complications like arrhythmia or heart failure. Recently, Diagnostics World covered efforts to improve diagnostic and treatment options for sarcoidosis.

    Jul 18, 2024
  • Digital Endpoints Gaining Ground in Industry-Sponsored Trials

    Diagnostics World | A recent analysis of interventional clinical trials by the Tufts Center for the Study of Drug Development (CSDD) has found that use of digital endpoints has been growing rapidly since 2015 with drug developers now initiating an average of about 35 such studies each year. News of the uptick isn’t entirely surprising, given mounting evidence that the approach can improve operational performance and ease patient burdens in clinical trials and in clinical practice, while [potentially] yielding financial net benefits to developers.

    Jul 16, 2024
  • Cool New Tech Tricks for Tackling Speed Bumps in Point-of-Care Histology

    Diagnostics World | For more than 150 years now, medical scientists have been hunching over microscopes turning human tissue samples into crisp colored images that help pathologists diagnose diseases. Histology, as the field is known, has made an art of the complex business of creating high-quality microscope slides—and until recently done it in precisely the same way with consistently good results.

    Jul 11, 2024
  • AI Taking on the Holy Grail of Diagnostics: Predicting Drug Response

    Diagnostics World | Machine learning models can be superior to radiologists when it comes to processing complex images and putting a predictive label on them, particularly at scale. The problems currently being studied in biomedicine with machine learning, such as identifying the subtype of cancer a patient has, are ones that have been largely ignored for a long time.

    Jul 10, 2024
  • Proscia, Nucleai Partner to Link Digital Pathology, AI-Predictive Biomarker Platforms

    Diagnostics World | Proscia and Nucleai are partnering to integrate Nucleai’s predictive biomarker solutions into Proscia’s Concentriq software platform and make them available as part of Proscia’s AI-enabled pathology portfolio to better inform patient care.

    Jul 9, 2024
  • New AI System Detects Rare Forms of Epilepsy Better Than Traditional Models

    Diagnostics World | Over 3.4 million people in the US and 65 million people worldwide are affected by epilepsy. To ensure that patients are getting the treatment they need, early detection is critical. Researchers at the University of Southern California have developed an AI system called NeuroGNN that can identify epilepsy by analyzing brain interactions with greater accuracy and efficiency.

    Jul 1, 2024
  • Follow the Money: Foresite Therapeutics’ New Fund Invests in Precision Therapeutics, Targeting Autoimmune, Inflammatory Diseases, More

    Diagnostics World | Foresite Capital launches fund for three main areas: precision therapeutics, life science infrastructure, and healthcare delivery; Santa Ana Bio employs proteomic, transcriptomic, and genomic approaches to precisely characterize disease-specific subpopulations and identify targets only on disease-causing cell types leaving healthy cells unaffected; more.

    Jun 27, 2024
  • PacBio’s Free HiFi Long-Read Variant Frequency Database, PathAI Releases New AI Products, Thermo Fisher Unveils New Pipetting System, More

    Diagnostics World | PacBio, in collaboration with the international Consortium for Long-Read Sequencing (CoLoRS), announced the launch of the first publicly available and free HiFi long-read variant frequency database with global representation; PathAI unveiled two novel AI products, PathExplore Immuno-Oncology Profiling (IOP) and IHC Explore1; , Thermo Fisher Scientific has introduced One Lambda HLA PRO, an automated, modular pipetting system that offers versatility by accommodating different workflows on a single instrument, allowing laboratories to automate multiple human leukocyte antigen (HLA) and antibody testing technologies cost-effectively; more.

    Jun 26, 2024
  • GRAIL Begins Independent Trading on Nasdaq

    Diagnostics World | GRAIL, previously an Illumina company, began regular trading on Nasdaq today under the ticker symbol "GRAL." Illumina continues to trade on Nasdaq under the ticker symbol "ILMN."

    Jun 25, 2024
  • Wearable Device Identifies Biomarker for Malignant Melanoma

    Diagnostics World | Researchers at the Karolinska Institute in Stockholm, Sweden, have developed a new device for detecting malignant melanoma. Melanoma affects about one million people every year across the world, and over the past two decades, cases of melanoma have significantly increased due to higher rates of exposure to ultraviolet radiation and climate change.

    Jun 21, 2024
  • AI-Powered Platform Could Reveal True Personality of Tumors

    Diagnostics World | Researchers in Israel who pioneered the discipline of “mechanomics” are now using the concept to fill the chasm between the expanding volume of ‘omics data and its translation into real-world clinical scenarios. Their aim is to help physicians predict the aggressiveness of cancer and a tumor’s potential resistance to treatment and, ultimately, improve patient outcomes.

    Jun 18, 2024
  • New Biomarker Offers Hope of Detecting Alzheimer's in Asymptomatic Stages

    Diagnostics World | Until recently, all the available therapeutic options for treating Alzheimer’s disease were designed to reduce symptoms rather than address causes of the disease. But with two beta-amyloid antibodies now approved by the U.S. Food and Drug Administration, and tau-targeting agents in clinical trials, hopes are rising that Alzheimer’s progression can be delayed if not stopped.

    Jun 12, 2024
  • Sarcoidosis Test Aims to Speed, Simplify Diagnostic Process

    Diagnostics World | Sarcoidosis is difficult to diagnose for a variety of reasons. For one, it is not limited to a single area or part of the body. Although the vast majority of people living with sarcoidosis have it in their lungs, it can also appear in the eyes, the skin, brain, heart, spinal cord, liver, kidney, and even in the bones.

    Jun 11, 2024
  • Blood Test Could Improve Diagnosis of Severe Strokes on a Global Scale

    Diagnostics World | A potentially game-changing diagnostic assay is under development that can quickly and accurately identify who is and isn’t having a large vessel occlusion (LVO), a devastating subset of ischemic stroke that occurs when a major artery in the brain is blocked.

    Jun 6, 2024